Stockreport

Intellia Therapeutics Shares Slip Despite Strong Phase 3 Data [Yahoo! Finance]

Intellia Therapeutics, Inc.  (NTLA) 
Last intellia therapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intelliatx.com/investor-overview
PDF followed the release of positive Phase 3 results for its hereditary angioedema (HAE) therapy. The data marks the first global Phase 3 outcome for an in vivo gene editing [Read more]